Pharmacist Intervention to Improve Smoking Cessation

A Remote Pharmacist Intervention to Improve Smoking Cessation

The goal of this study is to assess the effectiveness of a remote pharmacist intervention to help smokers quit.

The main questions it aims to answer are:

• Will smokers being screened for lung cancer with low-radiation-level chest computed tomography (CT) be willing to participate in this study and talk to the pharmacist about smoking cessation?
• Will those in the intervention group be more likely to report smoking cessation than those in the control group.

Participants in the intervention group will be asked to complete a baseline survey; speak with a pharmacist via phone call at baseline, 2 weeks, 4 weeks, 6 weeks, 8 weeks, 10 weeks, and 12 weeks; and complete an exit survey.

Participants in the control group will be asked to complete a baseline survey and an exit survey.

Inclusion Criteria:

• Current smoker
• Current patient in the Lung Cancer Screening Program

Exclusion Criteria:

• Unable to speak/read English
• Unable to provide their own written informed consent